Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Ranibizumab
Related studies linked through entity extraction aliases.
Lucentis Versus Mitomycin C During Glaucoma Surgery
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Ranibizumab for Neovascularization in Sickle Cell Retinopathy
- Status
- WITHDRAWN
- Phase
- NA
Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
The Ranibizumab Plus Transpupillary Thermotherapy for Neovascular Age-Related Macular Degeneration (AMD) Study
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
- Status
- COMPLETED
- Phase
- PHASE3
Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO
- Status
- COMPLETED
- Phase
- PHASE3
Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES)
- Status
- COMPLETED
- Phase
- NA
Ranibizumab Therapy for Non-arteritic Ischemic Optic Neuropathy
- Status
- COMPLETED
- Phase
- PHASE1
Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab
- Status
- UNKNOWN
- Phase
- PHASE3
Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON)
- Status
- WITHDRAWN
- Phase
- PHASE3
Ranibizumab Versus PDT for Presumed Ocular Histoplasmosis
- Status
- UNKNOWN
- Phase
- PHASE2
Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
- Status
- COMPLETED
- Phase
- PHASE3
Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
- Status
- UNKNOWN
- Phase
- PHASE4
Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration
- Status
- COMPLETED
- Phase
- NA
Evaluation of Dosing Interval of Higher Doses of Ranibizumab
- Status
- COMPLETED
- Phase
- PHASE4
Ranibizumab and Reduced Fluence PDT for AMD
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE2
Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)
- Status
- COMPLETED
- Phase
- PHASE3